| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2007 | EP1806402A2 CTLA4/CD28 ligands and uses therefor |
| 07/11/2007 | EP1806367A2 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/11/2007 | EP1806364A2 New anti-IGF-IR antibodies and their applications |
| 07/11/2007 | EP1806354A2 Amphoteric sterols and their use |
| 07/11/2007 | EP1806353A1 Antisense modulation of novel anti-apoptotic BCL-2-related proteins |
| 07/11/2007 | EP1806349A1 Antitumoral analogs |
| 07/11/2007 | EP1806348A2 Pyrido (2,3-D)Pyrimidines as inhibitors of cellular proliferation |
| 07/11/2007 | EP1806347A1 Aromatic-ring-fused pyrimidine derivative |
| 07/11/2007 | EP1806346A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 07/11/2007 | EP1806341A2 (+)Phenyl-(4-{4-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-phenyl}-piperidin-1-yl)-acetic acid methyl ester as lipid lowering agent |
| 07/11/2007 | EP1806338A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 07/11/2007 | EP1806152A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806151A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806139A2 Immune stimulation using chemically modified RNA |
| 07/11/2007 | EP1806138A1 Anti-tumor agents comprising boroproline compounds |
| 07/11/2007 | EP1806137A1 Therapeutic agent for glomerular disease |
| 07/11/2007 | EP1806136A1 Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy |
| 07/11/2007 | EP1806135A2 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 07/11/2007 | EP1806134A1 Agent and food for preventing/improving functional digestive disorder |
| 07/11/2007 | EP1806133A1 Method for modifying the ambience, and spray liquid and sprayer used in the method |
| 07/11/2007 | EP1806132A1 STAT3 PHOSPHORYLATION INHIBITOR AND Notch1 EXPRESSION INHIBITOR |
| 07/11/2007 | EP1806131A2 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 07/11/2007 | EP1806130A1 Solid pharmaceutical composition comprising irbesartan |
| 07/11/2007 | EP1806123A2 Storage-stable compositions of glycerol monoalkyl ethers |
| 07/11/2007 | EP1806121A1 Anti-graying preparation |
| 07/11/2007 | EP1806120A1 Composition for prevention or alleviation of pigmentation |
| 07/11/2007 | EP1805510A1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 07/11/2007 | EP1805202A2 Conjugates with anti-inflammatory activity |
| 07/11/2007 | EP1805201A1 15b-substituted steroids having selective estrogenic activity |
| 07/11/2007 | EP1805196A1 Substituted adenines and the use thereof |
| 07/11/2007 | EP1805187A1 Inhibitors of hepatitis c virus protease, and compositions and treatments using the same |
| 07/11/2007 | EP1805184A1 Imidazo-benzodiazepine derivatives |
| 07/11/2007 | EP1805183A1 Novel diazabicyclic aryl derivatives and their medical use |
| 07/11/2007 | EP1805181A1 Purine derivatives for use as adenosin a-2a receptor agonists |
| 07/11/2007 | EP1805180A1 Xanthine derivatives with hm74a receptor activity |
| 07/11/2007 | EP1805177A1 Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
| 07/11/2007 | EP1805176A2 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 07/11/2007 | EP1805175A1 Novel azaindole thiazolinones as anti-cancer agents |
| 07/11/2007 | EP1805174A1 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 07/11/2007 | EP1805173A2 7, 8, 9, 10- tetrahydro-imidazo [2,1-a] isoquinoline derivatives and their use as gastric acid secretion inhibitors |
| 07/11/2007 | EP1805172A1 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 07/11/2007 | EP1805171A2 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 07/11/2007 | EP1805170A1 Mif-inhibitors |
| 07/11/2007 | EP1805169A1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses |
| 07/11/2007 | EP1805166A1 Quinoline derivatives |
| 07/11/2007 | EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 07/11/2007 | EP1805164A2 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 07/11/2007 | EP1805161A2 Isomigrastatin analogs in the treatment of cancer |
| 07/11/2007 | EP1805160A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 07/11/2007 | EP1805159A1 Substituted carboxylic acids |
| 07/11/2007 | EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 07/11/2007 | EP1805157A2 Tricyclic spacer systems for nonlinear optical devices |
| 07/11/2007 | EP1805156A2 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| 07/11/2007 | EP1805155A1 Thrombopoietin activity modulating compounds and methods |
| 07/11/2007 | EP1805154A2 Pharmaceutical compositions |
| 07/11/2007 | EP1805148A2 Crystalline rosuvastatin intermediate |
| 07/11/2007 | EP1805147A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 07/11/2007 | EP1805142A2 Novel pyridine compounds, process for their preparation and compositions containing them |
| 07/11/2007 | EP1805141A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 07/11/2007 | EP1805139A2 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 07/11/2007 | EP1805138A1 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor |
| 07/11/2007 | EP1805136A1 Substituted phenylalkanoic acids |
| 07/11/2007 | EP1805135A2 Purification of cinacalcet |
| 07/11/2007 | EP1805134A2 4-aminotetracyclines and methods of use thereof |
| 07/11/2007 | EP1805132A2 Novel compounds |
| 07/11/2007 | EP1805129A1 (biphenyl) carboxylic acids and derivatives thereof |
| 07/11/2007 | EP1804919A2 Cgrp receptor antagonists |
| 07/11/2007 | EP1804821A2 Hcv ns3-ns4a protease inhibition |
| 07/11/2007 | EP1804814A2 Multi-purpose bio-material composition |
| 07/11/2007 | EP1804813A2 Formulations and methods for treatment of inflammatory diseases |
| 07/11/2007 | EP1804812A2 Fluorinated pyrroloý2,3-d¨pyrimidine nucleosides for the treatment of rna-dependent rna viral infection |
| 07/11/2007 | EP1804811A2 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus |
| 07/11/2007 | EP1804810A1 Methods using glycosaminoglycans for the treatment of kidney disease |
| 07/11/2007 | EP1804809A2 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor |
| 07/11/2007 | EP1804808A1 Pyridoxal-5-phosphate and stent for the treatment and prevention of atherosclerosis and restenosis |
| 07/11/2007 | EP1804807A2 Coadministration of tigecycline and digoxin |
| 07/11/2007 | EP1804806A2 Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof |
| 07/11/2007 | EP1804805A2 Use of aromatase inhibitors for the treatment of ectopic pregnancy |
| 07/11/2007 | EP1804804A2 Loxapine analogs and methods of use thereof |
| 07/11/2007 | EP1804803A2 Compounds and compositions as hedgehog pathway modulators |
| 07/11/2007 | EP1804802A2 Combination comprising zd6474 and an imatinib |
| 07/11/2007 | EP1804801A2 Methods of treating vascular injuries |
| 07/11/2007 | EP1804800A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-ý4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 07/11/2007 | EP1804799A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 07/11/2007 | EP1804798A2 Methods for the treatment of substance abuse and addiction |
| 07/11/2007 | EP1804797A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 07/11/2007 | EP1804796A2 Amino substituted aryloxybenzylpiperidine derivatives |
| 07/11/2007 | EP1804795A2 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
| 07/11/2007 | EP1804794A2 Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease |
| 07/11/2007 | EP1804793A2 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 07/11/2007 | EP1804792A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 07/11/2007 | EP1804791A1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 07/11/2007 | EP1804790A2 Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 07/11/2007 | EP1804789A2 Method of treating human preeclampsia employing resibufagenin |
| 07/11/2007 | EP1804787A2 Flavonoid composition for treating oral diseases |
| 07/11/2007 | EP1804786A2 Substituted n-aryl-9-oxo-9h-fluorene-1-carboxamides and analogs as activators of caspases and inducers of apoptosis |
| 07/11/2007 | EP1804785A2 Diaryl ureas as cb1 antagonists |